Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. - Wikidata - awgldk - TriplyDB

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

http://www.wikidata.org/entity/Q43038550

about

New virologic tools for management of chronic hepatitis B and C Usefulness of the Hepatitis C Virus Core Antigen Assay for Screening of a Population Undergoing Routine Medical Checkup Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals.Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection Comparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination Therapy Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins Assessment of Specific Antibodies to F Protein in Serum Samples from Chinese Hepatitis C Patients Treated with Interferon plus Ribavarin Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells Evaluation of Hepatitis C Virus Core Antigen Assays in Detecting Recombinant Viral Antigens of Various Genotypes Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification Hepatitis C virus infection.Hepatitis C treatment: where are we now?Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay.Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera.Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients Evaluation of an antigen-antibody "combination" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections.Use and interpretation of virological tests for hepatitis C.Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C Inhibition of hepatitis C virus production by aptamers against the core protein.Comparison of HCV core antigen and anti-HCV with HCV RNA results.Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease.Hepatitis C virus RNA tests: performance attributes and their impact on clinical utility.Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients Detection of hepatitis C virus core antigen in blood donors using a new enzyme immunoassay.Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.Chronic viral hepatitis in hemodialysis patients.Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples

P2860

Q27026914-EBD5E5F7-78D0-4C25-92D6-4D5EAFD13890 Q27469465-2541D3BD-286E-495C-9472-6254984C2AE1 Q27471998-D5E77CB1-FA20-45AB-9DC6-1B937BA52F52 Q27473088-00F9A3B7-0346-462D-85C3-497F058AA976 Q27473162-DAA71C94-4B7A-4398-9BF4-E7CC166AE82C Q27473492-C5697DAE-89EA-416E-B6A7-F1756EFC2EC8 Q27477674-EC40992C-D602-467D-9C3A-67ACAFF5000D Q27478083-3F6A70CB-0A9D-44F2-B36A-92E12CF51780 Q27478121-9E93A71A-9916-49C4-ABCC-45F05A80EA70 Q27480975-D642FF43-6BB6-4715-B82A-399A2414A4FA Q27487302-3060F53E-81A6-4E2D-8893-77F4D5D94AEE Q27488392-E8E8BD6E-4734-4F56-A10E-8D51E9752999 Q27490457-CB3C88D3-6458-42B3-BA93-E775184106AF Q27490515-06FB8787-258C-4047-92D1-EB8069BDE467 Q27491329-9F1F3AA7-FDD8-4775-ACCB-0600E5E4DF31 Q30235491-8D2912B5-C7A5-4ED5-92F6-D48ABF68128E Q30378509-29DF7505-4C35-452A-BFD2-3959A1A40343 Q30426257-DA668509-2915-4ECB-A5AE-205130A154DA Q30433630-DBED30A1-AEBB-461C-8F6B-A13CBE9D2BE0 Q33197019-FFC49DAD-B6AD-45C8-8159-577F539F852D Q33592250-71471FBA-0950-4680-91E2-2B803CF9D07B Q33592762-A7BDD925-949D-4FBD-A922-4824D51222C3 Q33712801-E47443E2-C015-4201-BC74-80C5892F673F Q33766292-3550743C-5D3B-4FBA-9507-EA5B534B10F3 Q33999798-4A2B2309-A809-4324-9545-944166BA7404 Q34008754-98D56D03-F82A-4CD6-B19E-16A64D3E9FE1 Q34475736-A1218B0D-A25C-4118-921C-733D4947EE5D Q34588996-A41E1296-920F-4BD8-8214-9949205B5F83 Q34984049-4311C4DB-F9C8-47E5-AC60-FB85A0B8A7F1 Q34991008-BF8B09FB-526E-4A94-BA79-E89B61D356DF Q35059404-B7C1FEC4-DD54-4439-91E9-D5212BCDC5B1 Q35207132-31A54976-DBEE-4E64-B415-3021B25BACC3 Q35237341-1205A555-FC1A-475A-BB8A-C20B426BB1AA Q35589284-96B9D29A-1696-4E21-9EC5-DEE87509D51A Q35599069-94C14318-20CF-480A-8E0A-1EB43A191890 Q35689119-87D188C4-AC44-4481-860D-A2E8DC93A22A Q36133920-096EA160-1BCB-46E8-B9C7-8F9CE9F3C2EB Q36258800-FA7B4A80-11AD-429A-BE77-4451CBF15179 Q36271099-B2BD1031-FEEC-4B47-9937-DD40098E4F03 Q36554189-763AF07F-5AFE-4866-9EB1-61310AAE8A82

P2860

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

http://www.wikidata.org/entity/Q43038550

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Clinical utility of total HCV ...... ect marker of HCV replication.

@en

Clinical utility of total HCV ...... ect marker of HCV replication.

@nl

type

label

Clinical utility of total HCV ...... ect marker of HCV replication.

@en

Clinical utility of total HCV ...... ect marker of HCV replication.

@nl

prefLabel

Clinical utility of total HCV ...... ect marker of HCV replication.

@en

Clinical utility of total HCV ...... ect marker of HCV replication.

@nl

P1433

Q43038550-1B5CB5D5-6280-49FE-B109-B8E87D14A739

P1476

Q43038550-209AA550-55E8-4BA3-864A-6C1FBB838C64

P2093

Q43038550-07A249C3-9082-4D35-87E3-0EA4423CABE2

Q43038550-28F0C308-7397-4410-978D-870DCD8F259A

Q43038550-2CEBE538-A398-4A11-B9B6-B3452ABD0F6C

Q43038550-66C392FE-5937-4DAE-8B85-243E6308F1CD

Q43038550-8182074F-0D75-441E-98CF-3EF1221ED188

Q43038550-9A399959-5D1E-4219-9EAC-037AABFFF421

Q43038550-BCDC672D-3706-4708-874F-7D3FC709D5B6

Q43038550-BE87BDE4-5294-4180-A2D3-73CB8ED1E98F

Q43038550-DB952D2C-F9F8-4C10-8F3C-24815B936452

Q43038550-E04A677F-7583-4542-A21B-A9BED40ABC78

P304

Q43038550-90FCDBC3-23AB-40F1-BE03-B29E6313468D

P31

Q43038550-B96F840C-ADDC-438D-B3F4-CF2D1643E26E

P356

Q43038550-EE679752-79BE-41DC-AC1E-BEECB5FD74AD

P407

Q43038550-5E7FD384-09E7-4A3D-A417-48ED8377349C

P433

Q43038550-6956E725-311D-4791-A9DC-247250A61DCA

P478

Q43038550-4816B0E0-3D15-4C26-9055-86935D20660F

P50

Q43038550-03E86D54-66D3-48EB-92C6-570CB2017684

Q43038550-0F9D0468-FE32-40B2-8F6D-01C8D3E8650D

P577

Q43038550-7813E317-83B3-4D39-A1D4-3060F20447E4

P5875

Q43038550-7514EE5C-12BE-4907-86A0-0723EB845AB5

P698

Q43038550-DFFFFC44-AA04-4BAA-A016-47F82EFF3AD1

P356

JHEP.2002.34130

P1433

P1476

Clinical utility of total HCV ...... ect marker of HCV replication.

@en

P2093

Avidan U Neumann

http://www.w3.org/2001/XMLSchema#string

Christophe Hezode

http://www.w3.org/2001/XMLSchema#string

Daniel Dhumeaux

http://www.w3.org/2001/XMLSchema#string

Gaston Picchio

http://www.w3.org/2001/XMLSchema#string

Harel Dahari

http://www.w3.org/2001/XMLSchema#string

John G McHutchison

http://www.w3.org/2001/XMLSchema#string

Keyur Patel

http://www.w3.org/2001/XMLSchema#string

Lawrence Blatt

http://www.w3.org/2001/XMLSchema#string

Magali Bouvier-Alias

http://www.w3.org/2001/XMLSchema#string

Patrick Larderie

http://www.w3.org/2001/XMLSchema#string

P304

211-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2002.34130

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Pawlotsky

Magali Bouvier-Alias

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11290704

http://www.w3.org/2001/XMLSchema#string

P698

12085367

http://www.w3.org/2001/XMLSchema#string